Keurig Dr Pepper Inc. Common Stock vs Medtronic PLC — how do they compare? Keurig Dr Pepper Inc. Common Stock trades at $31.76 (market cap $42.54B), while Medtronic PLC trades at $88.67 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 2.6× Keurig Dr Pepper Inc. Common Stock's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Keurig Dr Pepper Inc. Common Stock for 1 Days and Medtronic PLC for 63 Days on average.
| KDP | MDT | |
|---|---|---|
Market Cap | $42.54B | $112.24B |
Volume | 14,530,234 | 105,663,236 |
Sector | Consumer Staples | Health |
52-Week High | $33.50 | $105.35 |
52-Week Low | $25.31 | $73.75 |
Typical Hold Time | 1 Days | 63 Days |
Enterprise Value | $71.00B | $131.58B |
Dividend Yield | 2.94% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.
Read more on KDP →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →